Healthcare Industry News: Procter & Gamble
News Release - January 4, 2006
Synova Healthcare, Inc. Announces Chief Scientific OfficerMEDIA, Pa., Jan. 4 (HSMN NewsFeed) -- Synova Healthcare, Inc., a wholly owned subsidiary of Synova Healthcare Group, Inc. (OTC Bulletin Board: SNVH ), today announced that Ron Spangler, Ph.D. has joined the Company as its Chief Scientific Officer. In this capacity, Dr. Spangler will be primarily responsible for orchestrating all product development at Synova, including the development of the recently announced non-invasive fetal monitor.
Prior to joining Synova, Dr. Spangler was most recently Managing Director of Investment Banking at Keystone Equities Group where his primary focus was healthcare and biotechnology. Dr. Spangler received his B.S. and M.S. degrees in Molecular Biology and his Ph.D. in Physiology and Biophysics. He continued his education as a NIH postdoctoral scholar in the department of internal medicine at the University of Michigan. After completing his postdoctoral training, Dr. Spangler joined The Procter & Gamble Company where he was responsible for their clinical research and development programs, supporting well-known consumer brands including Metamucil®, Pepto-Bismol®, Vicks® and NyQuil® to name a few. Following his tenure at Procter & Gamble, Dr. Spangler was Director of Worldwide Strategic Product Development for SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline), where he worked on several key brands including Tagamet®, Coreg® and Hycamtin®. Dr. Spangler has previously served as General Partner of Coherent Capital Management, L.P. and Managing Director of Research for Emerging Growth Equities, Ltd. Dr. Spangler has also authored more than 40 books and manuscripts covering a broad range of scientific disciplines.
"We continue to build what we view as a strong organization in order to effectively manage our new product launches and growth expectations for 2006 and beyond," stated Mr. Stephen King, Chief Executive Officer of Synova. "We are very pleased to welcome Dr. Spangler to our management team; particularly given both the breadth and depth of his scientific expertise and his clinical and commercial experience."
About Synova Healthcare Group, Inc.:
Synova Healthcare Group, Inc., (OTC Bulletin Board: SNVH ), presently operates two wholly owned subsidiaries: Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company develops and distributes rapid, non- invasive medical diagnostics to retail for over-the-counter (OTC) use, and also directly to health care providers for point of care (POC) use in the clinical setting. The company's products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This Press Release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Source: Synova Healthcare
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.